# Tacrolimus Blood Concentration and Transplant-related Outcomes in Pediatric HSCT Recipients

> **NCT06080490** · — · COMPLETED · sponsor: **University of Pisa** · enrollment: 125 (actual)

## Conditions studied

- Graft Vs Host Disease
- Transplant Failure
- Stem Cell Transplant Complications

## Interventions

- **DRUG:** TAC C/D ratio

## Key facts

- **NCT ID:** NCT06080490
- **Lead sponsor:** University of Pisa
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-29
- **Primary completion:** 2024-09-29
- **Final completion:** 2024-12-31
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06080490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06080490, "Tacrolimus Blood Concentration and Transplant-related Outcomes in Pediatric HSCT Recipients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06080490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*